Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kalion is a synthetic biology company that specializes in the production of high-purity glucaric acid and its derivatives through advanced fermentation processes. The company utilizes proprietary microbial strains to convert renewable feedstocks into high-value chemicals, providing a sustainable and cost-competitive alternative to traditional petrochemical synthesis. Their primary product, glucaric acid, has diverse applications ranging from pharmaceutical and nutraceutical ingredients to industrial uses in water treatment and biodegradable polymers. Kalion's technology platform addresses the historical challenges of high production costs and low purity that have limited the market adoption of glucaric acid. By enabling large-scale, "green" manufacturing, the company supports the development of bio-based products across multiple sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kalion.